Back
Akero Therapeutics Stock Price Chart
Sponsored
AKRO
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61
AKRO
Akero Therapeutics
Last Price:
31.22
Seasonality Move:
5.92%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...- The current trend is relatively stagnant and AKRO is experiencing slight selling pressure.
Akero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.68 | Sell |
20-day SMA: | 31.41 | Sell |
50-day SMA: | 29.63 | Buy |
200-day SMA: | 25.21 | Buy |
8-day EMA: | 30.77 | Sell |
20-day EMA: | 30.97 | Sell |
50-day EMA: | 29.78 | Buy |
200-day EMA: | 27.2 | Buy |
Akero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.2 | Buy |
Relative Strength Index (14 RSI): | 49.43 | Sell |
Chaikin Money Flow: | -52673 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.33 - 33.05) | Sell |
Bollinger Bands (100): | (24.84 - 30.44) | Buy |
Akero Therapeutics Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 30.64 while AKRO 8-day simple moving average is 30.68, which is a Sell signal.
- The stock price of AKRO is 30.64 while Akero Therapeutics 20-day SMA is 31.41, which makes it a Sell.
- Akero Therapeutics 50-day simple moving average is 29.63 while AKRO share price is 30.64, making it a Buy technically.
- AKRO stock price is 30.64 and Akero Therapeutics 200-day simple moving average is 25.21, creating a Buy signal.
AKRO Technical Analysis vs Fundamental Analysis
Buy
61
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a Buy
The current Akero Therapeutics [AKRO] share price is $30.64. The Score for AKRO is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Akero Therapeutics Stock Info
Market Cap:
2.14B
Price in USD:
30.64
Share Volume:
443.22K
Akero Therapeutics 52-Week Range
52-Week High:
37.00
52-Week Low:
15.32
Buy
61
Akero Therapeutics (AKRO)
is a Buy
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?
The Akero Therapeutics stock price is 30.64 USD today. -
Will AKRO stock go up or go down?
Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Akero Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is not overvalued.
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 30.64 while AKRO 8-day exponential moving average is 30.77, which is a Sell signal.
- The stock price of AKRO is 30.64 while Akero Therapeutics 20-day EMA is 30.97, which makes it a Sell.
- Akero Therapeutics 50-day exponential moving average is 29.78 while AKRO share price is 30.64, making it a Buy technically.
- AKRO stock price is 30.64 and Akero Therapeutics 200-day simple moving average is 27.20, creating a Buy signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
- AKRO Moving Average Covergence Divergence (MACD) indicator is 0.2, suggesting Akero Therapeutics is a Buy
- Akero Therapeutics Relative Strength Index (RSI) is 49.43, which suggest Akero Therapeutics is oversold
- The Bollinger Bands (25) for Akero Therapeutics is (29.33 - 33.05), which suggest Akero Therapeutics is a Buy
- The Bollinger Bands (100) for Akero Therapeutics is (24.84 - 30.44), which suggest Akero Therapeutics is a Buy
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.